臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 26-50 of 1137 (46 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-06-27T07:07:53Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; CHONG-JEN YU; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-06-27T07:07:53Z	Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern	Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; CHONG-JEN YU; Tsai M.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:51Z	Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer	Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; CHONG-JEN YU; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:07:49Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; CHONG-JEN YU; Cheng A.-L.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:47Z	Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer	Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; Ho C.-C.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:45Z	Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer	Lee J.-H.; CHONG-JEN YU; Chen K.-Y.; Shih J.-Y.; Lin Y.-L.; Yang C.-H.
臺大學術典藏	2022-06-27T07:07:45Z	Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors	Chen K.-Y.; Chen J.-H.; Shih J.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:44Z	Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer	Wu J.-Y.; CHONG-JEN YU; Shih J.-Y.; Yang C.-H.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:44Z	Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors	Lin C.-C.; Hsu H.-H.; Sun C.-T.; Shih J.-Y.; Lin Z.-Z.; CHONG-JEN YU; Chen G.G.; Hsin M.K.Y.; Lam K.C.; Leung L.; Yang C.-H.; Mok T.
臺大學術典藏	2022-06-27T07:07:42Z	Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer	Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; CHONG-JEN YU; Chang S.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:40Z	Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations	Chung K.-P.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T07:07:39Z	Epidermal growth factor receptor mutations in small cell lung cancer: A brief report	Shiao T.-H.; Chang Y.-L.; CHONG-JEN YU; Chang Y.-C.; Hsu Y.-C.; Chang S.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:39Z	The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma	Kuo Y.-W.; Jerng J.-S.; Shih J.-Y.; Chen K.-Y.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:36Z	Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations	Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:35Z	Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer	Wu J.-Y.; CHONG-JEN YU; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:35Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	Wu S.-G.; Yang C.-H.; CHONG-JEN YU; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:32Z	Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction	Wu S.-G.; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; CHONG-JEN YU; Shih J.-Y.
臺大學術典藏	2022-06-27T07:07:31Z	Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations	Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; CHONG-JEN YU; Shih J.-Y.; Chang Y.-L.; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:31Z	Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed	Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:28Z	Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation	Lu C.-H.; Hsiao C.-H.; Chang Y.-C.; Lee J.-M.; Shih J.-Y.; Wu L.-A.; CHONG-JEN YU; Liu H.-M.; Shih T.T.-F.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:28Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Wu S.-G.; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; CHONG-JEN YU; Yang C.-H.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:27Z	Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum	Liao W.-Y.; Shih J.-Y.; Chang G.-C.; Cheng Y.-K.; Yang J.C.-H.; Chen Y.-M.; CHONG-JEN YU
臺大學術典藏	2022-06-27T07:07:27Z	Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma	Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:07:26Z	Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment	Chung K.-P.; Huang Y.-T.; Chang Y.-L.; CHONG-JEN YU; Yang C.-H.; Chang Y.-C.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:06:54Z	Elevated serum levels of mucin-associated antigen in patients with acute respiratory distress syndrome	Shih J.-Y.; Yang S.-C.; CHONG-JEN YU; Wu H.-D.; Liaw Y.-S.; Wu R.; Yang P.-C.

Showing items 26-50 of 1137 (46 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2826208
	???header.visitor??? : 31899979 ???header.onlineuser??? : 1587 ???header.sponsordeclaration???